CA1029026A - N2-dansyl-l-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof - Google Patents

N2-dansyl-l-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof

Info

Publication number
CA1029026A
CA1029026A CA206,760A CA206760A CA1029026A CA 1029026 A CA1029026 A CA 1029026A CA 206760 A CA206760 A CA 206760A CA 1029026 A CA1029026 A CA 1029026A
Authority
CA
Canada
Prior art keywords
dansyl
pharmaceutically acceptable
acid addition
addition salts
acceptable acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA206,760A
Other languages
English (en)
French (fr)
Other versions
CA206760S (en
Inventor
Shosuke Okamoto
Ryoji Kikumoto
Kazuo Ohkubo
Yoshikuni Tamao
Shinji Tonomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9069973A external-priority patent/JPS5521742B2/ja
Priority claimed from JP11603573A external-priority patent/JPS5521743B2/ja
Priority claimed from JP11729273A external-priority patent/JPS5521744B2/ja
Priority claimed from JP13750173A external-priority patent/JPS5521745B2/ja
Priority claimed from JP3114174A external-priority patent/JPS5542073B2/ja
Priority claimed from JP3326074A external-priority patent/JPS5521746B2/ja
Priority claimed from JP6157374A external-priority patent/JPS5542074B2/ja
Application filed by Mitsubishi Chemical Industries Ltd filed Critical Mitsubishi Chemical Industries Ltd
Application granted granted Critical
Publication of CA1029026A publication Critical patent/CA1029026A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
CA206,760A 1973-08-13 1974-08-09 N2-dansyl-l-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof Expired CA1029026A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP9069973A JPS5521742B2 (en, 2012) 1973-08-13 1973-08-13
JP11603573A JPS5521743B2 (en, 2012) 1973-10-16 1973-10-16
JP11729273A JPS5521744B2 (en, 2012) 1973-10-18 1973-10-18
JP13750173A JPS5521745B2 (en, 2012) 1973-12-10 1973-12-10
JP3114174A JPS5542073B2 (en, 2012) 1974-03-19 1974-03-19
JP3326074A JPS5521746B2 (en, 2012) 1974-03-25 1974-03-25
JP6157374A JPS5542074B2 (en, 2012) 1974-05-31 1974-05-31

Publications (1)

Publication Number Publication Date
CA1029026A true CA1029026A (en) 1978-04-04

Family

ID=27564271

Family Applications (1)

Application Number Title Priority Date Filing Date
CA206,760A Expired CA1029026A (en) 1973-08-13 1974-08-09 N2-dansyl-l-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof

Country Status (9)

Country Link
US (1) US4670420A (en, 2012)
CA (1) CA1029026A (en, 2012)
CH (4) CH612928A5 (en, 2012)
DE (1) DE2438851C2 (en, 2012)
DK (1) DK140431B (en, 2012)
FR (1) FR2240720B1 (en, 2012)
GB (1) GB1475346A (en, 2012)
NL (1) NL165652C (en, 2012)
NO (1) NO140344C (en, 2012)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7512637A (nl) * 1974-11-08 1976-05-11 Mitsubishi Chem Ind Werkwijze ter bereiding van een geneesmiddel, het aldus gevormde geneesmiddel en werkwijze voor de bereiding van actieve component.
CA1102316A (en) * 1975-12-09 1981-06-02 Shosuke Okamoto N su2 xx-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
FR2378004B2 (fr) * 1975-12-09 1985-09-13 Mitsubishi Chem Ind Derives de l'argininamide, leur preparation et leurs utilisations therapeutiques
EP0190852A3 (en) * 1985-01-31 1988-11-02 Ajinomoto Co., Inc. Dipeptide derivatives and antihypertensive drugs containing them
GB9504350D0 (en) * 1995-03-04 1995-04-26 Sod Conseils Rech Applic Arginine derivatives
CA2447314A1 (en) * 2001-05-15 2002-11-21 Atsuro Nakazato Arginine derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE420919B (sv) * 1973-08-13 1981-11-09 Mitsubishi Chem Ind Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
US4069329A (en) * 1974-11-08 1978-01-17 Mitsubishi Chemical Industries Limited N2 -Naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
US4072743A (en) * 1974-11-08 1978-02-07 Mitsubishi Chemical Industries Limited N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4069317A (en) * 1974-11-08 1978-01-17 Mitsubishi Chemical Industries Ltd. N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4072744A (en) * 1974-11-08 1978-02-07 Mitsubishi Chemical Industries Limited N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
NO140344B (no) 1979-05-07
CH612929A5 (en, 2012) 1979-08-31
DK140431B (da) 1979-08-27
FR2240720B1 (en, 2012) 1978-07-21
NL165652C (nl) 1981-05-15
DE2438851A1 (de) 1975-02-27
NO742886L (en, 2012) 1975-03-10
NL165652B (nl) 1980-12-15
DK140431C (en, 2012) 1980-01-28
CH613946A5 (en, 2012) 1979-10-31
FR2240720A1 (en, 2012) 1975-03-14
CH612928A5 (en, 2012) 1979-08-31
DE2438851C2 (de) 1987-03-19
CH613945A5 (en, 2012) 1979-10-31
DK429474A (en, 2012) 1975-04-21
NL7410647A (nl) 1975-02-17
GB1475346A (en) 1977-06-01
NO140344C (no) 1979-08-15
US4670420A (en) 1987-06-02

Similar Documents

Publication Publication Date Title
CA1001626A (en) Phenoxypropylamine derivatives and the preparation thereof
CA999589A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
CA999588A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
CA969549A (en) 2-anilino-nicotinic acid derivatives
CA1018171A (en) SUBSTITUTED .alpha.-AMINOOXYCARBOXYLIC ACID HYDRAZIDE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF
CA1004677A (en) 3,4-substituted-5-sulfamoyl benzoic acid derivatives
CA1026760A (en) 3,4-dihydro-2h-naphthalin-1-one-5-oxypropyl-piperazine derivatives
CA1029026A (en) N2-dansyl-l-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
AU464455B2 (en) 7-trichloroacetamido-3-desacetoxy-cephalosporanic acid derivatives, their preparation and use
CA1010036A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
AU499409B2 (en) Cephalasporanic acid derivatives
CA1036164A (en) Derivatives of 2-amino-indane, the preparation and use thereof
CA997786A (en) Derivatives of 2-amino-indane, the preparation and use thereof
CA1029726A (en) 1,8-naphthyridine-3-carboxamidetetrazolyl derivatives
AU464456B2 (en) 7-monochloroacetamido-3-desacetoxy-cephalosporanic acid derivatives, their preparation and use
CA1014549A (en) Methyleneaminopenicillanic acid derivatives
CA1033728A (en) Pharmaceutically useful prostanoic acid derivatives
CA1001627A (en) Phenoxypropylamine derivatives and the preparation thereof
CA1026746A (en) 2,3-lower alkylenepenam-3-carboxylic acid derivatives and processes for the preparation thereof
AU439063B2 (en) New phenoxy-alkyl-carboxylic acid derivatives and the preparation thereof
AU492554B2 (en) 6-alkyl-9,10-dihydro-2' b-methyl-5'-benzyl-ergopeptide derivatives
AU487415B2 (en) 3-substituted 8, 9-diaza [3,2,2] - bicyclonan derivatives
AU7582674A (en) 6-alkyl-9,10-dihydro-2' b-methyl-5'-benzyl-ergopeptide derivatives
AU490372B2 (en) 1, 2-diphenylethanolamine derivatives and their salts and the preparation thereof
AU487239B2 (en) 2, 3-methanoprostaglandin derivatives